Perspectives on Liver and Kidney Transplantation in the Human Immunodeficiency Virus-Infected Patient

被引：8

作者：

Chin-Hong, Peter ^{[1
]}

Beatty, George ^{[2
]}

Stock, Peter ^{[3
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] UCSF Posit Hlth Care Program, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2013年 / 27卷 / 02期

关键词：

Human immunodeficiency virus; Transplantation; Hepatitis B; Hepatitis C; Liver; Kidney; INOSINE MONOPHOSPHATE DEHYDROGENASE; ACTIVE ANTIRETROVIRAL THERAPY; RENAL-TRANSPLANTATION; DOSING MODIFICATIONS; MYCOPHENOLIC-ACID; HIV; RECIPIENTS; DISEASE; CYCLOSPORINE; SURVIVAL;

D O I：

10.1016/j.idc.2013.02.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

Human immunodeficiency virus (HIV) infection is no longer an absolute contraindication for transplantation for patients with advanced kidney and liver failure. This article reviews the outcome data in the solid organ transplantation of HIV-infected patients that led to a change in thinking by the transplant community. Several emerging issue's are also reviewed, such as eligibility criteria, selection of optimal immunosuppression agents and antiretroviral therapy in this population, and management of coinfection with hepatitis B and hepatitis C after transplant.

引用

页码：459 / +

页数：14

共 38 条

[1]

Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression [J].

Abbott, KC ;

Swanson, SJ ;

Agodoa, LYC ;

Kimmel, PL .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1633-1639

[2]

Beatty G, 2011, 6 IAS C HIV PATH TRE

[3]

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients [J].

Coffin, C. S. ;

Stock, P. G. ;

Dove, L. M. ;

Berg, C. L. ;

Nissen, N. N. ;

Curry, M. P. ;

Ragni, M. ;

Regenstein, F. G. ;

Sherman, K. E. ;

Roland, M. E. ;

Terrault, N. A. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) :1268-1275

[4]

Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].

Dean, M ;

Carrington, M ;

Winkler, C ;

Huttley, GA ;

Smith, MW ;

Allikmets, R ;

Goedert, JJ ;

Buchbinder, SP ;

Vittinghoff, E ;

Gomperts, E ;

Donfield, S ;

Vlahov, D ;

Kaslow, R ;

Saah, A ;

Rinaldo, C ;

Detels, R ;

OBrien, SJ .

SCIENCE, 1996, 273 (5283) :1856-1862

[5]

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].

Doranz, BJ ;

Rucker, J ;

Yi, YJ ;

Smyth, RJ ;

Samson, M ;

Peiper, SC ;

Parmentier, M ;

Collman, RG ;

Doms, RW .

CELL, 1996, 85 (07) :1149-1158

[6]

ERICE A, 1991, REV INFECT DIS, V13, P537

[7]

Changing the natural history of HIV disease [J].

Feinberg, MB .

LANCET, 1996, 348 (9022) :239-246

[8]

CC chemokine receptor 5 and renal-transplant survival [J].

Fischereder, M ;

Luckow, B ;

Hocher, B ;

Wüthrich, RP ;

Rothenpieler, U ;

Schneeberger, H ;

Panzer, U ;

Stahl, RAK ;

Hauser, IA ;

Budde, K ;

Neumayer, HH ;

Krämer, BK ;

Land, W ;

Schlöndorff, D .

LANCET, 2001, 357 (9270) :1758-1761

[9]

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients [J].

Frassetto, L ;

Baluom, M ;

Jacobsen, W ;

Christians, U ;

Roland, ME ;

Stock, PG ;

Carlson, L ;

Benet, LZ .

TRANSPLANTATION, 2005, 80 (01) :13-17

[10]

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients [J].

Frassetto, L. A. ;

Browne, M. ;

Cheng, A. ;

Wolfe, A. R. ;

Roland, M. E. ;

Stock, P. G. ;

Carlson, L. ;

Benet, L. Z. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) :2816-2820

← 1 2 3 4 →